influenza vaccine, recombinant hemagglutinin
Vaccineexperimental
Clinical trial activity
14 trials · 32 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
7
Phase 3
7
Phase 4
4
Earliest trial started Nov 1, 2004 (NCT00328107)
Timeline
Indications
Approved for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- flublok
- flublok
- flublok
- influenza vaccine, recombinant hemagglutinin
- umn 05
- umn-05
- umn0501
- umn 0501
- umn-0501
- umn-0501
- vaxsyn inflenza
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07240922 | Phase 4 | Oct 1, 2025 | The University of Hong Kong |
| NCT06118151 | Phase 1 | Apr 11, 2022 | Sanofi-Aventis |
| NCT03598439 | Phase 4 | Jul 30, 2018 | Centers for Disease Control and Prevention (CDC), Marshfield Clinic Research Foundation |
| NCT03300050 | Phase 1 | Oct 10, 2017 | Duke University, GlaxoSmithKline, Icahn School of Medicine at Mount Sinai, PATH, The EMMES Corporation, University of Cincinnati |
| NCT03068949 | Phase 4 | Oct 28, 2015 | National Institutes of Health (NIH), University of Rochester |
| NCT02285998 | Phase 3 | Oct 1, 2014 | Protein Sciences Corp |
| NCT02290509 | Phase 3 | Oct 1, 2014 | Benchmark Research, Department of Health and Human Services, INC Research, Protein Sciences Corp |
| NCT01959945 | Phase 3 | Nov 1, 2013 | Protein Sciences Corp |
| NCT01825200 | Phase 3 | Mar 1, 2013 | Benchmark Research, Clinical Research Center of Nevada, LLC, Clinical Research of South Florida, Genova Clinical Research, Heartland Research Associates, LLC, Maine Research Associates, Meridien Research, MRA Clinical Research, Protein Sciences Corp, Rapid Medical Research, Inc., Regional Clinical Research, Research Across America, Wake Forest University |
| NCT01752881 | Phase 4 | Aug 1, 2012 | Adimmune Corporation, National Cheng Kung University |
| NCT00980447 | Phase 2 | Oct 1, 2009 | Kitasato University, UMN Pharma Inc. |
| NCT00539981 | Phase 3 | Sep 1, 2007 | Protein Sciences Corp, University of Rochester |
| NCT00539864 | Phase 3 | Sep 1, 2007 | Kaiser Permanente, Protein Sciences Corp |
| NCT00328107 | Phase 2/Phase 3 (Phase 3) | Nov 1, 2004 | Protein Sciences Corp, University of Rochester |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (32)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Protein Sciences Corp | For profit | 7 | 7 | 1 | 2004 |
| University of Rochester | Academic/Hospital | 3 | 1 | 2 | 2004 |
| Benchmark Research | For profit | 2 | 0 | 1 | 2013 |
| Adimmune Corporation | For profit | 1 | 1 | 1 | 2012 |
| Centers for Disease Control and Prevention (CDC) | Government | 1 | 0 | 1 | 2018 |
| Clinical Research Center of Nevada, LLC | For profit | 1 | 0 | 1 | 2013 |
| Clinical Research of South Florida | For profit | 1 | 0 | 1 | 2013 |
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2014 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Genova Clinical Research | For profit | 1 | 0 | 1 | 2013 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2017 |
| Heartland Research Associates, LLC | For profit | 1 | 0 | 1 | 2013 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 0 | 1 | 2017 |
| INC Research | For profit | 1 | 0 | 1 | 2014 |
| Kaiser Permanente | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Kitasato University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Maine Research Associates | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Marshfield Clinic Research Foundation | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Meridien Research | For profit | 1 | 0 | 1 | 2013 |
| MRA Clinical Research | Academic/Hospital | 1 | 0 | 1 | 2013 |
32 organizations
Page 1 / 2